SUBSCRIBE
SUBSCRIBE

AstraZeneca

NEWS
Policy
U.S. Judge Levies Damages in AstraZeneca PLC (Jobs), Bristol-Myers Squibb Company (Jobs), Warrick Pharmaceuticals Drug Pricing Case
June 22, 2007
 · 
1 min read
Biotech Beach
China Week In Review: Simcere Pharma Files for American IPO
March 26, 2007
 · 
1 min read
Drug Development
AstraZeneca PLC(Jobs)'s Crestor Not As Effective As Hoped
March 26, 2007
 · 
1 min read
AstraZeneca PLC(Jobs) Pledges $10M To Cancer Society
February 15, 2007
 · 
1 min read
Pharm Country
The Day In Review: Wyeth And AstraZeneca PLC Sign More Deals
February 5, 2007
 · 
1 min read
Biotech Beach
The Day In Review: AstraZeneca PLC Enters Two Partnerships
January 31, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Amgen (Jobs) Rises On Speculation Over Patent Suit
January 22, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Bristol-Myers Squibb Company In $1.2 Billion Pact With AstraZeneca PLC
January 11, 2007
 · 
1 min read
Bio NC
The Day In Review: Targacept, Inc. Climbs On AstraZeneca PLC Payment
December 27, 2006
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
TRUQAP® (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer
May 1, 2026
 · 
15 min read
Press Releases
Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca
April 29, 2026
 · 
3 min read
Press Releases
AstraZeneca results: Q1 2026
April 29, 2026
 · 
8 min read
Press Releases
BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
April 28, 2026
 · 
12 min read
Press Releases
SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus
April 27, 2026
 · 
16 min read
Press Releases
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
April 20, 2026
 · 
6 min read
Press Releases
Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD
April 20, 2026
 · 
10 min read
Press Releases
Saphnelo® subcutaneous approved in Canada for the treatment of systemic lupus erythematosus
April 14, 2026
 · 
9 min read
Press Releases
IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer
April 2, 2026
 · 
19 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer
March 9, 2026
 · 
19 min read
Load More